PME share price has been in steady and persistent decline for months, almost as if there was some awareness by some that the coys business growth outlook might not be as good as expected towards the end of 2017.
Given the presentation at the 2017 AGM, where a quite positive picture was painted about its technological advantages, the further development of complementary technology, its ability to well price its products and services, its high success rate with moving from tenders to contracts, and the favourable regulatory environment in the USA in particular for driving business opportunities, the market may be concerned about the lack of announcement of contract successes since December, which lack might be sapping investor confidence.
Does anybody have a feel whether the business growth outlook of PME has deteriorate?
- Forums
- ASX - By Stock
- PME
- Sure Price Trend
Sure Price Trend
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PME (ASX) to my watchlist
(20min delay)
|
|||||
Last
$227.64 |
Change
5.890(2.66%) |
Mkt cap ! $17.90B |
Open | High | Low | Value | Volume |
$225.00 | $229.57 | $223.37 | $80.03M | 351.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $227.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$227.72 | 3210 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1231 | 14.800 |
1 | 1231 | 14.760 |
1 | 293 | 14.750 |
1 | 510 | 14.730 |
1 | 941 | 14.720 |
Price($) | Vol. | No. |
---|---|---|
14.830 | 466 | 1 |
14.840 | 1685 | 1 |
14.860 | 771 | 1 |
14.870 | 677 | 1 |
14.880 | 941 | 2 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
PME (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online